Values as of: 2024-04-22
ETF | China Region | NYSE Arca
Last Closing
USD 66.3Change
+0.97 (+1.48)%Market Cap
USD 0.83BVolume
0.02MAnalyst Target
N/AVerdict
Verdict
The investment seeks investment results that, before fees and expenses, correspond generally to the total return performance of the S&P China BMI Index. The fund generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index or in American Depositary Receipts ("ADRs") or Global Depositary Receipts ("GDRs") based on securities comprising the index. The index is a market capitalization weighted index designed to define and measure the investable universe of publicly traded companies domiciled in China available to foreign investors. The fund is non-diversified.
Company Website : www.spdrs.com
Currency: USD
Country : USA
Inception Date: 19/03/2007
Primary Benchmark: S&P China BMI NR USD
Primary Index: MSCI ACWI Ex USA NR USD
Gross Expense Ratio: 0.59%
Management Expense Ratio: 0.59 %
N/A
N/A
N/A
N/A
| Symbol | Name | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|
| KWEB | KraneShares CSI China Internet.. | 0.75 % |
+0.50 (+1.66%) |
USD 5.72B |
| FXI | iShares China Large-Cap ETF | 0.74 % |
+0.18 (+0.66%) |
USD 4.39B |
| EWT | iShares MSCI Taiwan ETF | 0.59 % |
+0.75 (+1.57%) |
USD 4.11B |
| ASHR | Xtrackers Harvest CSI 300 Chin.. | 0.65 % |
+0.05 (+0.20%) |
USD 1.69B |
| CQQQ | Invesco China Technology ETF | 0.70 % |
+0.14 (+0.38%) |
USD 0.60B |
| EWH | iShares MSCI Hong Kong ETF | 0.48 % |
+0.11 (+0.66%) |
USD 0.49B |
| CHIQ | Global X MSCI China Consumer D.. | 0.65 % |
+0.23 (+1.20%) |
USD 0.23B |
| FLTW | Franklin FTSE Taiwan ETF | 0.19 % |
+0.57 (+1.32%) |
USD 0.22B |
| KBA | KraneShares Bosera MSCI China .. | 0.60 % |
+0.04 (+0.18%) |
USD 0.19B |
| FLCH | Franklin FTSE China ETF | 0.19 % |
+0.11 (+0.63%) |
USD 0.12B |
| Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|---|
| MCRO | 0.00 % | 0.76 % |
N/A |
N/A | |
| QAI | IQ Hedge Multi-Strategy T.. | 0.00 % | 0.54 % |
+0.15 (+0.47%) |
USD 0.57B |
| Market Performance vs. Industry/Classification (China Region) | Market Performance vs. Exchange (NYSE Arca) | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | -2.67% | 50% | F | 34% | F | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | -2.67% | 50% | F | 29% | F | ||
| Trailing 12 Months | |||||||
| Capital Gain | -15.70% | 60% | D- | 16% | F | ||
| Dividend Return | 3.20% | 79% | B- | 48% | F | ||
| Total Return | -12.50% | 70% | C- | 16% | F | ||
| Trailing 5 Years | |||||||
| Capital Gain | -35.35% | 50% | F | 17% | F | ||
| Dividend Return | 8.04% | 55% | F | 28% | F | ||
| Total Return | -27.32% | 50% | F | 15% | F | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | -4.00% | 35% | F | 23% | F | ||
| Dividend Return | -2.44% | 35% | F | 17% | F | ||
| Total Return | 1.57% | 60% | D- | 38% | F | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 25.55% | 70% | C- | 44% | F | ||
| Risk Adjusted Return | -9.53% | 35% | F | 21% | F | ||
| Market Capitalization | 0.83B | 70% | C- | 45% | F | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
There is nothing we particularly like
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
